PIPERAZINE ALS ANTIMALARIAMITTEL

European patent · EP2521715 · Deleted

Register entry

Publication number
EP2521715
Application number
EP11702702
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 4, 2011
Published
Nov 14, 2012
Granted
Jun 25, 2014
Deleted
Aug 24, 2024
Reason
Annual fee unpaid
IPC classes
C07D 213/56 (2006.01)
C07D 213/64 (2006.01)
C07D 295/185 (2006.01)
A61K 31/495 (2006.01)
A61K 31/496 (2006.01)
A61P 33/02 (2006.01)
A61P 33/06 (2006.01)
Priority
WO PCT/IB2010/052045 10.05.2010
WO PCT/IB2010/050022 05.01.2010
PCT application
PCT/IB2011/050009 04.01.2011
PCT publication
WO2011/083413 14.07.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2024

    Deleted, fee unpaid

    Published in Swissreg on 24.08.2024

  2. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  3. Sep 14, 2017

    Transferred

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

  4. Jun 25, 2014

    Granted

    Published in Swissreg on 25.06.2014

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.